Jane Street Group LLC Invests $703,000 in Electromed, Inc. (NYSE:ELMD)

Jane Street Group LLC purchased a new position in shares of Electromed, Inc. (NYSE:ELMD - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 23,807 shares of the company's stock, valued at approximately $703,000. Jane Street Group LLC owned 0.28% of Electromed at the end of the most recent reporting period.

Other hedge funds have also recently bought and sold shares of the company. Aristides Capital LLC raised its position in Electromed by 4.7% in the 4th quarter. Aristides Capital LLC now owns 26,076 shares of the company's stock valued at $771,000 after buying an additional 1,159 shares during the last quarter. Russell Investments Group Ltd. acquired a new stake in shares of Electromed in the fourth quarter valued at approximately $37,000. IFP Advisors Inc bought a new stake in shares of Electromed in the fourth quarter worth $59,000. Barclays PLC boosted its holdings in Electromed by 25.0% during the fourth quarter. Barclays PLC now owns 12,529 shares of the company's stock worth $371,000 after purchasing an additional 2,507 shares during the last quarter. Finally, Quantbot Technologies LP acquired a new stake in Electromed in the 4th quarter valued at $99,000. 40.82% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

ELMD has been the subject of a number of analyst reports. B. Riley raised shares of Electromed to a "strong-buy" rating in a research report on Thursday, May 15th. Wall Street Zen cut Electromed from a "strong-buy" rating to a "buy" rating in a report on Thursday, May 8th.

Electromed Stock Down 2.6%

ELMD traded down $0.53 during trading on Friday, reaching $19.88. 1,861 shares of the stock traded hands, compared to its average volume of 85,905. The stock has a market capitalization of $166.71 million, a PE ratio of 26.51 and a beta of 0.46. The stock's 50-day moving average is $22.36 and its 200 day moving average is $27.06. Electromed, Inc. has a 12 month low of $13.74 and a 12 month high of $35.56.

Electromed announced that its board has authorized a stock buyback plan on Monday, March 10th that authorizes the company to buyback $5.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 2.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company's board believes its stock is undervalued.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.